National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 517800

History of Changes from the VAERS Wayback Machine

First Appeared on 4/14/2014

517800
VAERS Form:
Age:
Gender:Female
Location:Foreign
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2013-12-27
Entered:2013-12-27
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / - UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Hidradenitis

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit? (V2.0) No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Immunisation
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': WAES1312FRA010466

Write-up:Case received via a media press article and from a lawyer on 17-Dec-2013 from Sanofi Pasteur (reference # FR-1577272925-E2013-11075) on 20-DEC-2013. Case linked with serious cases E2013-11083, E2013-11084, E2013-11086 and E2013-11087. Within the context of 9 complaints filing concern the occurrence of adverse events following vaccination with the GARDASIL (information mentioned in the media press), it was reported by the complainants'' lawyer, by the media press, that in the weeks or months following vaccination with GARDASIL (batch numbers not reported), 4 female patients presented with a very disabling Verneuil''s disease. The patients were aged between 18 and 24 years, or approximately 40 for one of them. At the time of reporting, the outcome was unknown. No further information was available which could enable a duplicate search of the case.


Changed on 6/14/2014

517800 Before After
VAERS Form:
Age:
Gender:Female
Location:Foreign
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2013-12-27
Entered:2013-12-27
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / - UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Hidradenitis

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit? (V2.0) No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Immunisation
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': WAES1312FRA010466

Write-up:Case received via a media press article and from a lawyer on 17-Dec-2013 from Sanofi Pasteur (reference # FR-1577272925-E2013-11075) on 20-DEC-2013. Case linked with serious cases E2013-11083, E2013-11084, E2013-11086 and E2013-11087. Within the context of 9 complaints filing concern the occurrence of adverse events following vaccination with the GARDASIL (information mentioned in the media press), it was reported by the complainants'' lawyer, by the media press, that in the weeks or months following vaccination with GARDASIL (batch numbers not reported), 4 female patients presented with a very disabling Verneuil''s disease. The patients were aged between 18 and 24 years, or approximately 40 for one of them. At the time of reporting, the outcome was unknown. No further information was available which could enable a duplicate search of the case.


Changed on 3/14/2015

517800 Before After
VAERS Form:
Age:
Gender:Female
Location:Foreign
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2013-12-27
Entered:2013-12-27
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / - UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Hidradenitis

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit? (V2.0) No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Immunisation
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': WAES1312FRA010466

Write-up:Case received via a media press article and from a lawyer on 17-Dec-2013 from Sanofi Pasteur (reference # FR-1577272925-E2013-11075) on 20-DEC-2013. Case linked with serious cases E2013-11083, E2013-11084, E2013-11086 and E2013-11087. Within the context of 9 complaints filing concern the occurrence of adverse events following vaccination with the GARDASIL (information mentioned in the media press), it was reported by the complainants'' lawyer, by the media press, that in the weeks or months following vaccination with GARDASIL (batch numbers not reported), 4 female patients presented with a very disabling Verneuil''s disease. The patients were aged between 18 and 24 years, or approximately 40 for one of them. At the time of reporting, the outcome was unknown. No further information was available which could enable a duplicate search of the case.


Changed on 9/14/2017

517800 Before After
VAERS Form:(blank) 1
Age:
Gender:Female
Location:Foreign
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2013-12-27
Entered:2013-12-27
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / - UNK UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Hidradenitis

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit? (V2.0) No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Immunisation
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': WAES1312FRA010466

Write-up:Case received via a media press article and from a lawyer on 17-Dec-2013 from Sanofi Pasteur (reference # FR-1577272925-E2013-11075) on 20-DEC-2013. Case linked with serious cases E2013-11083, E2013-11084, E2013-11086 and E2013-11087. Within the context of 9 complaints filing concern the occurrence of adverse events following vaccination with the GARDASIL (information mentioned in the media press), it was reported by the complainants'' lawyer, by the media press, that in the weeks or months following vaccination with GARDASIL (batch numbers not reported), 4 female patients presented with a very disabling Verneuil''s disease. The patients were aged between 18 and 24 years, or approximately 40 for one of them. At the time of reporting, the outcome was unknown. No further information was available which could enable a duplicate search of the case.


New Search

Link To This Search Result:

http://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=517800&WAYBACKHISTORY=ON


Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166